2 terminated. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Terminated 2 |
Follow IgA Nephropathy: new trials by email Literature Review of IgA Nephropathy trials Research Report on IgA Nephropathy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of the Safety and Efficacy of OMS721 in Patients With Immunoglobulin A (IgA) Nephropathy OMS721, Vehicle (D5W or saline) - IgA Nephropathy | Phase 3 | Terminated | Omeros Corporation | 360 | 2018-04-05 | 2025-12-09 |
| Mycophenolate Mofetil (MMF) in Patients With IgA Nephropathy Mycophenolate Mofetil (MMF), MMF Placebo, ACEi - IgA Nephropathy | Phase 3 | Terminated | St. Joseph's Hospital and Medical Center, Phoenix | 184 | 2002-01-01 | 2016-03-07 |
Glomerulonephritis, IGA (2) · Proteinuria (2) · Renal Insufficiency, Chronic (1)
Autoimmune Diseases (2) · Female Urogenital Diseases (2) · Female Urogenital Diseases and Pregnancy Complications (2) · Glomerulonephritis (2) · Immune System Diseases (2) · Kidney Diseases (2) · Male Urogenital Diseases (2) · Nephritis (2) · Pathological Conditions, Signs and Symptoms (2) · Signs and Symptoms (2) · Urination Disorders (2) · Urogenital Diseases (2) · Urologic Diseases (2) · Urological Manifestations (2) · Chronic Disease (1)
Angiotensin-Converting Enzyme Inhibitors (1) · Mycophenolic Acid (1) · Sodium Chloride (1) · narsoplimab (1)
Omeros Corporation (1) · St. Joseph's Hospital and Medical Center, Phoenix (1)
United States (2) · Argentina (1) · Australia (1) · Belgium (1) · Bulgaria (1) · Canada (1) · Czechia (1) · Germany (1) · Greece (1) · Hungary (1) · India (1) · Italy (1) · Lithuania (1) · Poland (1) · Singapore (1)